Chromatography Standards
Apexbio Technology LLC ANTI-PD-1 NIVOLUMAB-5mg
Anti-PDCD1/PD-1/CD279 Antibody (Nivolumab) (CAS No 946414-94-4) is a monoclonal antibody widely studied in immunotherapy research originating from humanized antibodies It targets the PD-1 pathway an immune checkpoint that when inhibited can enhance the body s immune response against various cancer cells This antibody functions by blocking the interaction between PD-1 and its ligands PD-L1 and PD-L2 thus restoring the function of T-cells in the tumor microenvironment Common in vitro activity is observed in the nanomolar to low micromolar range It is typically used in cellular assays animal models and drug screening to assess immune response modulation and tumor inhibition Experimental concentrations typically depend on the specific research design
Cayman Chemical ImatInIb-d3 500ug
An internal standard for the quantification of imatinib by GC- or LC-MS
Sigma Aldrich Fine Chemicals Biosciences Triolein United States Pha50MG
This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.for further information and support please go to the website of the issuing Pharmacopoeia.
Sigma Aldrich Fine Chemicals Biosciences Levofloxacin Related Compound E United States Pharmacopeia (USP) Reference Standard | 1346603-62-0 | 25MG
Levofloxacin Related Compound E United States Pharmacopeia (USP) Reference Standard | Mol Wt: 371.79 | 1346603-62-0 | 25MG
Sigma Aldrich Fine Chemicals Biosciences Losartan Related Compound D United States Pharmacopeia (USP) Reference Standard | 212316-86-4 | 20MG
Losartan Related Compound D United States Pharmacopeia (USP) Reference Standard | Mol Wt: 865.9 | 212316-86-4 | 20MG
Sigma Aldrich Fine Chemicals Biosciences Trospium impurity C European Pharmacopoeia (EP) Reference Standard | 3464-71-9 |
Trospium impurity C European Pharmacopoeia (EP) Reference Standard | Mol Wt: 217.74 | 3464-71-9 |
Sigma Aldrich Fine Chemicals Biosciences Dopexamine dihydrochloride European Pharmacopoeia (EP) Reference Standard | 86484-91-5 |
Dopexamine dihydrochloride European Pharmacopoeia (EP) Reference Standard | Mol Wt: 429.42 | 86484-91-5 |
Sigma Aldrich Fine Chemicals Biosciences Triglycerol diisostearate European Pharmacopoeia (EP) Reference Standard | 66082-42-6 |
Triglycerol diisostearate European Pharmacopoeia (EP) Reference Standard | Mol Wt: 773.17 | 66082-42-6 |
Sigma Aldrich Fine Chemicals Biosciences Gemfibrozil British Pharmacopoeia (BP) Reference Standard | 25812-30-0 | MFCD00079335 |
Gemfibrozil British Pharmacopoeia (BP) Reference Standard | Mol Wt: 250.33 | 25812-30-0 | MFCD00079335 |
Medchemexpress LLC Suplatast (Tosilate) | 94055-76-2 | 499.64 | 50 MG
Suplatast Tosilate (IPD 1151T) is an orally active Th2 cytokine inhibitor that inhibits both IL-4 and IL-5 production from Th2 cells and suppresses IgE synthesis. It is an anti-allergic agent with antiasthmatic, anti-inflammatory, and antifibrotic activity.
- Orally active Th2 cytokine inhibitor
- Inhibits IL-4 and IL-5 production
- Suppresses IgE synthesis
- Anti-allergic agent
- Antiasthmatic activity
- Anti-inflammatory activity
- Antifibrotic activity